293780.KQ | AptaBio Therapeutics Inc. Annual & Quarterly

Annual Balance Sheets

(In KRW)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	92.51 Billion	56.11 Billion	64.91 Billion	75.44 Billion	77.4 Billion	20.32 Billion
Total Current Assets	57.47 Billion	20.41 Billion	23.77 Billion	43.74 Billion	46.76 Billion	19.94 Billion
Cash And Short Term Investments	52.88 Billion	16.99 Billion	22.91 Billion	42.82 Billion	46.15 Billion	19.69 Billion
Cash and Cash Equivalents	26.01 Billion	2.98 Billion	6.56 Billion	14.68 Billion	16.6 Billion	4.31 Billion
Short Term Investments	26.86 Billion	14 Billion	16.34 Billion	28.13 Billion	29.55 Billion	15.38 Billion
Net Receivables	2.83 Billion	3.13 Billion	500.65 Million	702.38 Million	342.75 Million	185.21 Million
Inventory	-	1.00	-	-	-	-
Other Current Assets	1.75 Billion	288.77 Million	365.55 Million	217.7 Million	266.08 Million	66.67 Million
Total Non-Current Assets	35.04 Billion	35.69 Billion	41.13 Billion	31.69 Billion	30.63 Billion	382.03 Million
Net PPE	4.75 Billion	5.84 Billion	4.82 Billion	4.88 Billion	4.03 Billion	287.08 Million
Good Will And Intangible Assets	61.08 Million	37.83 Million	41.99 Million	47.13 Million	13.24 Million	-
Good Will	-	-	-	-	-	-
Intangible Assets	61.08 Million	37.83 Million	41.99 Million	47.13 Million	13.24 Million	-
Long-Term Investments	29.65 Billion	29.67 Billion	36.2 Billion	26.59 Billion	26.59 Billion	86.81 Million
Tax Assets	2.00	3.00	3.00	-	30.6 Billion	-
Other Non Current Assets	575.16 Million	135.47 Million	64.89 Million	164.72 Million	-30.6 Billion	8.13 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	38.19 Billion	3.74 Billion	3.24 Billion	3.4 Billion	2.24 Billion	2.01 Billion
Total Current Liabilities	817.95 Million	1.04 Billion	787.57 Million	801.23 Million	730.85 Million	1.17 Billion
Account Payables	-	-	-	-	-	919.16 Million
Tax Payables	1.48 Million	-	-	-	-	-
Short Term Debt	131.07 Million	109.72 Million	54.56 Million	26.17 Million	25.37 Million	-
Deferred Revenue	-	-	-	-	-	20.26 Million
Other Current Liabilities	686.87 Million	930.28 Million	733 Million	775.05 Million	705.48 Million	236.29 Million
Total Non Current Liabilities	37.37 Billion	2.7 Billion	2.45 Billion	2.6 Billion	1.51 Billion	840.91 Million
Long-Term Debt	13.56 Billion	256.3 Million	46.77 Million	34.93 Million	-	-
Deferred Revenue Non Current	233.44 Million	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	16.53 Billion	2.44 Billion	2.41 Billion	2.56 Billion	1.51 Billion	840.91 Million
Other Liabilities	-	-	-	-	1.00	-
Total Equity	54.32 Billion	52.36 Billion	61.66 Billion	72.04 Billion	75.15 Billion	18.31 Billion
Stock Holders Equity	54.32 Billion	52.36 Billion	61.66 Billion	72.04 Billion	75.15 Billion	18.31 Billion
Common Stock	11.66 Billion	11.14 Billion	11.09 Billion	5.54 Billion	5.44 Billion	4.33 Billion
Retained Earnings	-87.74 Billion	-68.47 Billion	-58.2 Billion	-47.57 Billion	-42.69 Billion	-36.01 Billion
Accumulated other comprehensive income	10.8 Billion	668.63 Million	600.09 Million	349.14 Million	1.38 Billion	606.36 Million
Common Stock Equity	54.32 Billion	52.36 Billion	61.66 Billion	72.04 Billion	75.15 Billion	18.31 Billion
Capital Lease Obligation	233.44 Million	256.3 Million	46.77 Million	34.93 Million	61.1 Million	-
Total Investments	56.52 Billion	43.67 Billion	52.54 Billion	54.73 Billion	56.14 Billion	15.46 Billion
Total Debt	13.93 Billion	366.03 Million	101.34 Million	61.1 Million	86.48 Million	-
Net Debt	-12.08 Billion	-2.62 Billion	-6.46 Billion	-14.62 Billion	-16.51 Billion	-4.31 Billion

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Total Assets	88.75 Billion	89.88 Billion	92.51 Billion	92.51 Billion	100.94 Billion	50.05 Billion
Total Current Assets	57.51 Billion	55.17 Billion	57.47 Billion	57.47 Billion	71.99 Billion	21.52 Billion
Cash And Short Term Investments	48.9 Billion	50.07 Billion	52.88 Billion	52.88 Billion	69.3 Billion	18.81 Billion
Cash and Cash Equivalents	38.12 Billion	26.07 Billion	26.01 Billion	26.01 Billion	33.62 Billion	6.07 Billion
Short Term Investments	10.77 Billion	23.99 Billion	26.86 Billion	26.86 Billion	35.67 Billion	12.74 Billion
Net Receivables	2.68 Billion	3.15 Billion	2.83 Billion	2.83 Billion	2.51 Billion	2.55 Billion
Inventory	-	32.87 Million	-	-	-	-
Other Current Assets	5.92 Billion	1.91 Billion	1.75 Billion	1.75 Billion	184.55 Million	154.21 Million
Total Non-Current Assets	31.24 Billion	34.7 Billion	35.04 Billion	35.04 Billion	28.94 Billion	28.52 Billion
Net PPE	4.94 Billion	5.01 Billion	4.75 Billion	4.75 Billion	5.86 Billion	5.79 Billion
Good Will And Intangible Assets	49.91 Million	55.46 Million	61.08 Million	61.08 Million	27.11 Million	30.52 Million
Good Will	-	-	-	-	-	-
Intangible Assets	49.91 Million	55.46 Million	61.08 Million	61.08 Million	27.11 Million	30.52 Million
Long-Term Investments	26.03 Billion	29.43 Billion	29.65 Billion	29.65 Billion	22.72 Billion	22.39 Billion
Tax Assets	-49.91 Million	-55.46 Million	2.00	2.00	4.00	-4.00
Other Non Current Assets	260.26 Million	258.74 Million	575.16 Million	575.16 Million	331.02 Million	307.56 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	38.19 Billion	32.36 Billion	38.19 Billion	38.19 Billion	36.88 Billion	4.28 Billion
Total Current Liabilities	2.16 Billion	1.07 Billion	817.95 Million	817.95 Million	3.27 Billion	1.37 Billion
Account Payables	145.73 Million	12.03 Million	-	-	-	-
Tax Payables	-	-	1.48 Million	1.48 Million	-	-
Short Term Debt	159.79 Million	155.22 Million	131.07 Million	131.07 Million	130.11 Million	111.48 Million
Deferred Revenue	-	-	-	-	-	-
Other Current Liabilities	1.85 Billion	906.84 Million	686.87 Million	686.87 Million	3.14 Billion	1.26 Billion
Total Non Current Liabilities	36.02 Billion	31.29 Billion	37.37 Billion	37.37 Billion	33.6 Billion	2.9 Billion
Long-Term Debt	15.43 Billion	14.47 Billion	13.56 Billion	13.56 Billion	16.6 Billion	273.59 Million
Deferred Revenue Non Current	-	-	233.44 Million	233.44 Million	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	20.58 Billion	16.82 Billion	16.53 Billion	16.53 Billion	17 Billion	2.63 Billion
Other Liabilities	1.00	-	-	-	-	-
Total Equity	50.56 Billion	57.51 Billion	54.32 Billion	54.32 Billion	64.05 Billion	45.76 Billion
Stock Holders Equity	50.56 Billion	57.51 Billion	54.32 Billion	54.32 Billion	64.05 Billion	45.76 Billion
Common Stock	11.66 Billion	11.66 Billion	11.66 Billion	11.66 Billion	11.66 Billion	11.14 Billion
Retained Earnings	-91.71 Billion	-84.67 Billion	-87.74 Billion	-87.74 Billion	-79.26 Billion	-75.09 Billion
Accumulated other comprehensive income	11 Billion	10.92 Billion	10.8 Billion	10.8 Billion	12.05 Billion	689.52 Million
Common Stock Equity	50.56 Billion	57.51 Billion	54.32 Billion	54.32 Billion	64.05 Billion	45.76 Billion
Capital Lease Obligation	184.49 Million	176.86 Million	233.44 Million	233.44 Million	266.56 Million	273.59 Million
Total Investments	36.8 Billion	53.42 Billion	56.52 Billion	56.52 Billion	58.4 Billion	35.13 Billion
Total Debt	15.78 Billion	14.8 Billion	13.93 Billion	13.93 Billion	16.99 Billion	385.07 Million
Net Debt	-22.34 Billion	-11.27 Billion	-12.08 Billion	-12.08 Billion	-16.62 Billion	-5.68 Billion

Balance Sheet Charts

Kolon TissueGene, Inc.

950160

Full Analysis

Annual Balance Sheets
Intergis Co., Ltd

129260

Full Analysis

Annual Balance Sheets
JEOL Ltd.

JELLF

Full Analysis

Annual Balance Sheets
Copa Holdings, S.A.

CPA

Full Analysis

Annual Balance Sheets
Riverstone Energy Limited

RSE

Full Analysis

Annual Balance Sheets
Willow Biosciences Inc.

CANSF

Full Analysis

Annual Balance Sheets

Global Stocks Search

AptaBio Therapeutics Inc. (293780.KQ)

Annual Balance Sheets

Balance Sheet Charts

Kolon TissueGene, Inc.

Intergis Co., Ltd

JEOL Ltd.

Copa Holdings, S.A.

Riverstone Energy Limited

Willow Biosciences Inc.